Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2023.1227707 Immunology Retraction Retraction: Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart Frontiers Editorial Office *

Approved by: Pietro Ghezzi, University of Urbino Carlo Bo, Italy

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

05 06 2023 2023 14 1227707 23 05 2023 23 05 2023 Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart by Chen X, Zhao M-Z, Miao B-P, Liu Z-Q, Yang G, Liu J-Q, Yang P-C and Song J-P (2020) Immunol. 11:1955. doi: 10.3389/fimmu.2020.01955 section-in-acceptance Inflammation

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Immunology- Inflammation and the Chief Executive Editor of Frontiers. The authors agree to respond to correspondence regarding this retraction.